Buna Bhandari1,2, Padmanesan Narasimhan3, Abhinav Vaidya4, Madhusudan Subedi5, Rohan Jayasuriya3. 1. School of Population Health, The Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, 2052, Australia. bhbuna@gmail.com. 2. Central Department of Public Health, Tribhuvan University Institute of Medicine, Maharajgunj, Kathmandu, Nepal. bhbuna@gmail.com. 3. School of Population Health, The Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, 2052, Australia. 4. Department of Community Medicine, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal. 5. School of Public Health, Patan Academy of Health Sciences, Lalitpur, Nepal.
Abstract
BACKGROUND: Nepal has a high prevalence of hypertension which is a major risk factor for cardiovascular diseases globally. It is inadequately controlled even after its diagnosis despite the availability of effective treatment of hypertension. There is a need for an in-depth understanding of the barriers and facilitators using theory to inform interventions to improve the control of hypertension. This formative study was conducted to address this gap by exploring the perceived facilitators and barriers to treatment and control of hypertension in Nepal. METHODS: We conducted in-depth interviews (IDIs) among hypertensive patients, their family members, healthcare providers and key informants at primary (health posts and primary health care center) and tertiary level (Kathmandu Medical College) facilities in Kathmandu, Nepal. Additionally, data were collected using focus group discussions (FGDs) with hypertensive patients. Recordings of IDIs and FGDs were transcribed, coded both inductively and deductively, and subthemes generated. The emerging subthemes were mapped to the Capability, Opportunity, and Motivation-Behaviour (COM-B) model using a deductive approach. RESULTS: Major uncovered themes as capability barriers were misconceptions about hypertension, its treatment and difficulties in modifying behaviour. Faith in alternative medicine and fear of the consequences of established treatment were identified as motivation barriers. A lack of communication between patients and providers, stigma related to hypertension and fear of its disclosure, and socio-cultural factors shaping health behaviour were identified as opportunity barriers in the COM-B model. The perceived threat of the disease, a reflective motivator, was a facilitator in adhering to treatment. CONCLUSIONS: This formative study, using the COM-B model of behaviour change identified several known and unknown barriers and facilitators that influence poor control of blood pressure among people diagnosed with hypertension in Kathmandu, Nepal. These findings need to be considered when developing targeted interventions to improve treatment adherence and blood pressure control of hypertensive patients.
BACKGROUND: Nepal has a high prevalence of hypertension which is a major risk factor for cardiovascular diseases globally. It is inadequately controlled even after its diagnosis despite the availability of effective treatment of hypertension. There is a need for an in-depth understanding of the barriers and facilitators using theory to inform interventions to improve the control of hypertension. This formative study was conducted to address this gap by exploring the perceived facilitators and barriers to treatment and control of hypertension in Nepal. METHODS: We conducted in-depth interviews (IDIs) among hypertensivepatients, their family members, healthcare providers and key informants at primary (health posts and primary health care center) and tertiary level (Kathmandu Medical College) facilities in Kathmandu, Nepal. Additionally, data were collected using focus group discussions (FGDs) with hypertensivepatients. Recordings of IDIs and FGDs were transcribed, coded both inductively and deductively, and subthemes generated. The emerging subthemes were mapped to the Capability, Opportunity, and Motivation-Behaviour (COM-B) model using a deductive approach. RESULTS: Major uncovered themes as capability barriers were misconceptions about hypertension, its treatment and difficulties in modifying behaviour. Faith in alternative medicine and fear of the consequences of established treatment were identified as motivation barriers. A lack of communication between patients and providers, stigma related to hypertension and fear of its disclosure, and socio-cultural factors shaping health behaviour were identified as opportunity barriers in the COM-B model. The perceived threat of the disease, a reflective motivator, was a facilitator in adhering to treatment. CONCLUSIONS: This formative study, using the COM-B model of behaviour change identified several known and unknown barriers and facilitators that influence poor control of blood pressure among people diagnosed with hypertension in Kathmandu, Nepal. These findings need to be considered when developing targeted interventions to improve treatment adherence and blood pressure control of hypertensivepatients.
Authors: Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf Journal: JAMA Date: 2013-09-04 Impact factor: 56.272
Authors: Biraj M Karmacharya; Rajendra P Koju; James P LoGerfo; Kwun Chuen Gary Chan; Ali H Mokdad; Archana Shrestha; Nona Sotoodehnia; Annette L Fitzpatrick Journal: Heart Asia Date: 2017-01-04
Authors: Katherine T Mills; Joshua D Bundy; Tanika N Kelly; Jennifer E Reed; Patricia M Kearney; Kristi Reynolds; Jing Chen; Jiang He Journal: Circulation Date: 2016-08-09 Impact factor: 29.690
Authors: Sachita Shrestha; Archana Shrestha; Rajendra P Koju; James P LoGerfo; Biraj Man Karmacharya; Nona Sotoodehnia; Annette L Fitzpatrick Journal: Heart Asia Date: 2018-08-31
Authors: Will Maimaris; Jared Paty; Pablo Perel; Helena Legido-Quigley; Dina Balabanova; Robby Nieuwlaat; Martin McKee Journal: PLoS Med Date: 2013-07-30 Impact factor: 11.069
Authors: Eleni Rapsomaniki; Adam Timmis; Julie George; Mar Pujades-Rodriguez; Anoop D Shah; Spiros Denaxas; Ian R White; Mark J Caulfield; John E Deanfield; Liam Smeeth; Bryan Williams; Aroon Hingorani; Harry Hemingway Journal: Lancet Date: 2014-05-31 Impact factor: 79.321